SCHEMBL1356915

SCHEMBL1356915

Cc1cc(C)c2c(c1C)OC(C)(C)C(S(=O)(=O)O)C2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL569538 0.77 KDM4E (0.38) —
SCHEMBL1628640 0.69 PTGS1 (0.34) —
SCHEMBL2122059 0.67 — —
SCHEMBL11445907 0.66 ESR1 (0.35) —
SCHEMBL659527 0.64 ALDH1A1 (0.39) —
SCHEMBL10705687 0.64 — —
SCHEMBL10445564 0.64 — —
SCHEMBL5460830 0.64 PTGS1 (0.36) —
SCHEMBL2819365 0.63 — —
SCHEMBL3662900 0.63 HTT (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130244939-A1 NOVEL PEPTIDES THAT BIND TO THE ERYTHROPOIETIN RECEPTOR AFFYMAX, INC. (US) 2013-09-19 — — US disclosed
US-20130130979-A1 PEPTIDES THAT BIND TO THE ERYTHROPOIETIN RECEPTOR AFFYMAX, INC. (US) 2013-05-23 — — US disclosed
US-20130012685-A1 NOVEL PEPTIDES THAT BIND TO THE ERYTHROPOIETIN RECEPTOR AFFYMAX, INC. (US) 2013-01-10 — — US disclosed
US-8304391-B2 Peptides that bind to the erythropoietin receptor AFFYMAX, INC. (US) 2012-11-06 — — US disclosed
EP-1625156-B1 PEPTIDES THAT BIND TO THE ERYTHROPOIETIN RECEPTOR AFFYMAX INC (US) 2012-09-19 — — EP disclosed
US-8227422-B2 Peptides and compounds that bind to a receptor GLAXOSMITHKLINE LLC (US) 2012-07-24 — — US disclosed
CN-1966520-B Peptides and compounds that bind to a receptor GLAXO WELLCOME INC 2012-07-11 — — CN disclosed
US-20120157660-A1 NOVEL PEPTIDES THAT BIND TO THE ERYTHROPOIETIN RECEPTOR AFFYMAX, INC. (US) 2012-06-21 — — US disclosed
US-20110282029-A1 NOVEL PEPTIDES THAT BIND TO THE ERYTHROPOIETIN RECEPTOR AFFYMAX, INC. (US) 2011-11-17 — — US disclosed
EP-2338897-A1 Peptides and compounds that bind to a thrombopoietin receptor GLAXO GROUP LIMITED (GB) 2011-06-29 — — EP disclosed
US-5773569-A TREATMENT OF HUMAN DISEASES AFFYMAX TECHNOLOGIES N.V. (GB) 1998-06-30 — — US disclosed
US-5767234-A INTERLEUKIN AGONISTS AND ANTAGONISTS; ANTIINFLAMMATORY AND -ARTHRITIC AGENTS; SKIN, LIVER AND RESPIRATORY SYSTEM DISORDERS; IMMUNOLOGY AFFYMAX TECHNOLOGIES, N.V. (GB) 1998-06-16 — — US disclosed
US-5683983-A INHIBITS PRODUCTION AND ACCUMULATION OF EOSINOPHILS; ASTHMA; ANTIINFLAMMATORY,-ARTHRITIC AND ULCER AGENTS; OLIGOPEPTIDES, PEPTIDES AND PEPTIDE MIMETICS GLAXO GROUP LIMITED (GB) 1997-11-04 — — US disclosed
US-5677280-A INTERLEUKIN ANTAGONIST GLAXO GROUP LIMITED (GB) 1997-10-14 — — US disclosed
US-5668110-A Peptides and compounds that bind to the IL-5 receptor AFFYMAX TECHNOLOGIES N.V. (GB) 1997-09-16 — — US disclosed
US-5654276-A RESPIRATORY SYSTEM DISODERS; BINDING OF POLYPEPTIDE TO INTERLEULIN AFFYMAX TECHNOLOGIES N.V. (GB) 1997-08-05 — — US disclosed
US-5608035-A Peptides and compounds that bind to the IL-1 receptor AFFYMAX TECHNOLOGIES N.V. (GB) 1997-03-04 — — US disclosed
WO-1996040749-A1 COMPOUNDS AND PEPTIDES THAT BIND TO THE ERYTHROPOIETIN RECEPTOR JOHNSON & JOHNSON CORPORATION (US) 1996-12-19 — — WO disclosed
WO-1996040750-A1 PEPTIDES AND COMPOUNDS THAT BIND TO A THROMBOPOIETIN RECEPTOR GLAXO GROUP LIMITED (GB) 1996-12-19 — — WO disclosed
WO-1995020973-A1 PEPTIDES AND COMPOUNDS THAT BIND TO THE IL-1 RECEPTOR AFFYMAX TECHNOLOGIES N.V. (AN) 1995-08-10 — — WO disclosed
Send feedback